A detailed history of Wpg Advisers, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Wpg Advisers, LLC holds 61 shares of AXSM stock, worth $6,367. This represents 0.01% of its overall portfolio holdings.

Number of Shares
61
Previous 40 52.5%
Holding current value
$6,367
Previous $3.38 Million 110.22%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$80.05 - $137.75 $1,681 - $2,892
21 Added 52.5%
61 $7.11 Million
Q4 2024

May 15, 2025

BUY
$83.08 - $100.49 $3,323 - $4,019
40 New
40 $3.38 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.48B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Wpg Advisers, LLC Portfolio

Follow Wpg Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wpg Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wpg Advisers, LLC with notifications on news.